Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 9th May 2024 CHRS stock ended at $2.12. This is 4.93% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.35% from a day low at $2.11 to a day high of $2.27.
90 days $1.91 $2.87
52 weeks $1.44 $5.91

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Jul 06, 2016 $16.58 $17.13 $16.33 $16.51 338 200
Jul 05, 2016 $16.69 $17.07 $16.49 $16.66 176 600
Jul 01, 2016 $16.78 $17.45 $16.52 $16.84 227 600
Jun 30, 2016 $16.81 $16.90 $15.86 $16.89 426 400
Jun 29, 2016 $15.90 $17.58 $15.40 $16.79 390 000
Jun 28, 2016 $14.44 $15.99 $14.44 $15.64 289 300
Jun 27, 2016 $15.10 $15.16 $14.00 $14.13 270 000
Jun 24, 2016 $15.56 $16.00 $15.03 $15.32 866 700
Jun 23, 2016 $16.20 $16.80 $15.52 $16.47 147 500
Jun 22, 2016 $15.70 $16.62 $15.41 $16.02 224 600
Jun 21, 2016 $15.81 $15.81 $14.87 $15.69 235 300
Jun 20, 2016 $15.92 $16.49 $15.39 $15.63 144 300
Jun 17, 2016 $16.07 $16.07 $15.33 $15.57 363 600
Jun 16, 2016 $16.25 $16.25 $15.72 $16.01 134 191
Jun 15, 2016 $16.09 $16.59 $15.82 $16.44 263 178
Jun 14, 2016 $16.41 $16.84 $15.34 $16.00 330 557
Jun 13, 2016 $16.01 $16.87 $15.65 $16.51 453 273
Jun 10, 2016 $16.96 $17.02 $15.62 $16.01 876 259
Jun 09, 2016 $17.83 $18.17 $16.95 $16.95 371 844
Jun 08, 2016 $17.43 $18.15 $16.56 $18.04 436 893
Jun 07, 2016 $17.66 $18.06 $17.10 $17.42 740 957
Jun 06, 2016 $18.32 $18.32 $17.36 $17.81 192 130
Jun 03, 2016 $19.54 $19.54 $18.02 $18.28 861 717
Jun 02, 2016 $18.74 $19.70 $18.52 $19.47 504 368
Jun 01, 2016 $18.57 $19.00 $18.11 $18.88 597 035
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT